Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
BA3351 MurizatoclaxSummary: Murizatoclax (AMG397) is a potent, selective and orally active myeloid leukemia 1 inhibitor. -
BA3353 NPBSummary: NPB is a specific and potent inhibitor of phosphorylation. -
BA3355 BCL6-IN-4Summary: BCL6-IN-4 is a potent B-cell lymphoma 6 inhibitor with an IC50 of 97 nM. -
BA3356 Thevetiaflavone -
BA3357 PZ703bSummary: PZ703b is a degradative agent that induces apoptosis and inhibits cancer cell proliferation. -
BA3358 BAX-IN-1Summary: Potential, selective inhibitor of the related x protein (BAX). -
BA3359 BCL6-IN-5Summary: BCL6-IN-5 is a potent inhibitor. -
BA3360 Mcl1-IN-1Summary: Mcl1-IN-1 is a myeloid cytokine 1 inhibitor. -
BA3362 RK-9123016Summary: RK-9123016 is a potent inhibitor. -
BA3377 Ac-FLTD-CMKSummary: Ac-FLTD-CMK is an inhibitor derived from gephyrin D (GSDMD), a specific inhibitor of inflammation.


